Integrative molecular subtypes of acute myeloid leukemia
Blood Cancer J
.
2023 May 8;13(1):71.
doi: 10.1038/s41408-023-00836-4.
Authors
Qianxing Mo
#
1
,
Seongseok Yun
#
2
,
David A Sallman
2
,
Nicole D Vincelette
2
,
Guang Peng
3
,
Ling Zhang
4
,
Jeffrey E Lancet
2
,
Eric Padron
2
Affiliations
1
Department of Biostatistics & Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA. qianxing.mo@moffitt.org.
2
Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA.
3
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
4
Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA.
#
Contributed equally.
PMID:
37156780
PMCID:
PMC10167212
DOI:
10.1038/s41408-023-00836-4
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Leukemia, Myeloid, Acute* / genetics
Nucleophosmin
Substances
Nucleophosmin
Grants and funding
P30 CA076292/CA/NCI NIH HHS/United States
K08 CA237627/CA/NCI NIH HHS/United States